AI Automation — Life Sciences

AI Automation for Life Sciences & Pharmaceutical Companies

Life sciences companies operate in the most rigorously regulated environment in any commercial sector. MHRA requirements, ICH guidelines, GCP, GMP, GDP, ISO 13485 for medical devices — the documentation burden is not optional and the audit stakes are high. Much of this compliance work is structured: documents follow defined formats, reviews follow defined sequences, and data must be traceable from source to submission. AI automation in life sciences does not attempt to replace scientific judgement — it eliminates the administrative and process overhead surrounding it. We build regulatory document management systems that route submissions and amendments through defined approval workflows, clinical data pipelines that ingest and normalise data from multiple sources into analysis-ready formats, and quality management automation that maintains GxP-compliant records without requiring quality teams to chase every approval manually.

£94bn

UK life sciences sector turnover

280,000+

People employed in UK life sciences

60%

Reduction in regulatory document routing time

21 days

Document management workflow deployment time

Common pain points

  • ×Regulatory submission preparation consuming disproportionate quality and regulatory affairs team time
  • ×Clinical data arriving from multiple sites in inconsistent formats requiring manual normalisation
  • ×GxP document control relying on manual approval chasing that creates unnecessary delay

What we automate

  • ✓Regulatory submission workflow that routes CTAs, MAAs, and post-approval documents through defined approval sequences
  • ✓Clinical data ingestion pipeline normalising multi-site data into a consistent analysis-ready format
  • ✓GxP document control system automating SOP review cycles, approval routing, and training notifications

How AI automation works in Life Sciences

Life sciences companies generate document volumes that rival any other sector — clinical study reports, regulatory submissions, quality records, batch records, deviation investigations, supplier qualification evidence. The structured nature of regulatory documentation makes it suitable for automation: every document type has a defined format, every review follows a defined sequence, and every approval creates a traceable record that auditors will examine. We build document management automation for life sciences companies that enforces these structures: submission workflow routing that moves regulatory documents through the correct review and approval sequence, GxP SOP management that automates review cycle scheduling and training notifications, and clinical data pipelines that consolidate multi-site data into consistent formats ready for statistical analysis. The time recovered from manual document handling and approval chasing goes directly into the scientific and regulatory work that only humans can do.

Life sciences companies deploying regulatory document automation report 50-60% reductions in document routing and approval time, with improved regulatory inspection readiness.

AI automation in Life Sciences — overview

AI automation for UK life sciences and pharmaceutical companies addresses regulatory documentation, clinical data management, and quality system operations. Regulatory document workflow automation routes clinical trial applications, marketing authorisation submissions, and post-approval documents through defined approval sequences, maintaining a complete audit trail for MHRA and EMA inspection requirements. GxP document control automation manages SOP review cycles — triggering review notifications before expiry dates, routing amendments through defined approval sequences, and issuing training notifications when controlled documents are updated. Clinical data pipeline automation ingests data from multiple study sites in heterogeneous formats — EDC exports, lab systems, wearable devices — and normalises it into analysis-ready datasets. UK life sciences companies deploying document workflow automation report 50-60% reductions in routing and approval time, with material improvements in inspection readiness.

"Regulatory documentation in life sciences is not optional overhead — it is the evidence base that regulators evaluate. AI automation makes that evidence base more consistent, more traceable, and available faster than any manual document management process can achieve."

Technology stack

RAG systems built with Pinecone or Supabase pgvector for grounded, hallucination-free responses. Workflow orchestration via n8n (visual, auditable) or Python services for high-throughput or compliance-sensitive pipelines. LLM selection matched to task — frontier models for nuanced customer-facing responses, smaller classification models for routing and triage. REST API integrations into your CRM, helpdesk, and third-party tools. All deployments ship with documentation, audit logging, and exportable assets — no proprietary lock-in.

Frequently asked questions

What AI automation do you build for life sciences companies?▼
We build regulatory submission document management workflows, GxP SOP and quality record management automation, clinical data ingestion and normalisation pipelines, supplier qualification document workflows, and deviation and CAPA management automation. All systems are configured to the specific regulatory framework relevant to your product — MHRA, EMA, ICH, GCP/GMP/GDP, or ISO 13485 for medical devices.
How do you ensure GxP compliance in automated systems?▼
GxP-compliant automation requires full audit trail — who did what, when, and what data was used. Our systems maintain immutable audit logs of all document actions, approval decisions, and data processing steps. Access controls are configured to role-based permissions aligned with your quality system. Validation documentation — IQ, OQ, PQ where applicable — is produced as part of the deployment process.
Can automation assist with MHRA inspection readiness?▼
Yes. Inspection readiness requires being able to demonstrate that your quality system operated as documented during any given period. Automated document management maintains a complete, searchable record of all document versions, approval sequences, and training completion — the evidence that inspectors look for. We also build inspection query response automation that retrieves relevant records against specific MHRA or EMA inspection requests.
Do you work with medical device companies under MDR/IVDR?▼
Yes. Medical device companies under MDR and IVDR have specific document control and post-market surveillance requirements that we configure automation for: technical file management, UDI record management, post-market clinical follow-up scheduling, and vigilance reporting workflows. Configuration is done in collaboration with your regulatory affairs and quality teams.
How quickly does regulatory document workflow automation deploy?▼
GxP document workflow automation for a defined document set typically deploys in 4-8 weeks, including validation documentation. Clinical data pipelines for a defined source system deploy in 3-5 weeks. We always start with a discovery phase to map your current document types, review sequences, and system landscape before scoping the build. Validation requirements affect the timeline and are scoped explicitly.

Related services

Ai AutomationWorkflow Automation

Related industries

HealthcareHealthtech & Digital HealthPharmaceuticalsBiotech & Biosciences

Ready to automate your Life Sciences workflows?

Book a free 30-minute strategy call. We review your operations, identify the highest-impact automation opportunities, and give a straight answer on what is worth building.

Book a strategy callAI automation service